SCHEDULE: Armistice Capital Discloses 7.54% Stake in Orthofix
Beneficial Ownership Report
Armistice Capital, LLC and Steven Boyd have disclosed a 7.54% beneficial ownership stake in Orthofix Medical Inc., holding 2,978,000 shares.
Summary
- Armistice Capital, LLC and Steven Boyd are the reporting persons for this Schedule 13G/A filing.
- They collectively beneficially own 2,978,000 shares of Orthofix Medical Inc. common stock.
- This ownership represents 7.54% of Orthofix Medical Inc.'s outstanding common stock.
- The percentage is based on 39,494,265 shares outstanding as of July 31, 2025, as reported in Orthofix's Form 10-Q filed on August 5, 2025.
- Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., the direct holder of the shares.
- Steven Boyd, as the managing member of Armistice Capital, is also deemed to beneficially own these securities.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Orthofix Medical Inc.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership, indicating a passive investment. It does not contain positive or negative operational or financial news.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing indicates a significant passive investment by Armistice Capital, an investment adviser, in Orthofix Medical Inc., a company operating in the medical device sector. Such disclosures are common for institutional investors taking substantial, non-controlling stakes in publicly traded companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake, which can be viewed as a vote of confidence by a large investor.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement (reporting period end). |
| 07/31/2025 | Date as of which the number of outstanding shares (39,494,265) was reported by the Issuer. |
| 08/05/2025 | Date Orthofix Medical Inc. filed its Form 10-Q, reporting outstanding shares. |
| 08/14/2025 | Date of filing of this Schedule 13G/A. |
Keywords
Orthofix Medical Inc., Armistice Capital, Steven Boyd, Beneficial Ownership, Common Stock, SEC Filing, Schedule 13G, Medical Devices, Healthcare Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.